Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Roche Holding AG (OTCQX International Premier:RHHBY)

31.66
Delayed Data
As of Jul 26
 +0.14 / +0.44%
Today’s Change
29.89
Today|||52-Week Range
36.49
-8.15%
Year-to-Date
An Investing Overview of the Multiple Sclerosis Market
Jul 26 / MotleyFool.com - Paid Partner Content
3 Primary Ways Researchers Are Combatting Cancer
Jul 16 / MotleyFool.com - Paid Partner Content
Roche (RHHBY) Misses on Q2 Revenues, New Launches in Focus
Jul 25 / Zacks.com - Paid Partner Content
3 Stocks to Buy and Hold Forever
Jul 15 / MotleyFool.com - Paid Partner Content
Fresh Research Reports For Intel (INTC), AT&T (T) & Others
Jul 25 / Zacks.com - Paid Partner Content
Novartis' Enbrel Biosimilar Gets FDA Panel Recommendation
Jul 14 / Zacks.com - Paid Partner Content
In Case You Missed It, 5 New Lung Cancer Drugs Have Been Approved Since October
Jul 23 / MotleyFool.com - Paid Partner Content
Amgen and Daiichi Sankyo Team Up for Biosimilars in Japan
Jul 14 / Zacks.com - Paid Partner Content
Siegfried Holdings, Held by Tweedy Browne, Way Undervalued
Jul 22 / GuruFocus News - Paid Partner Content
5 Things Celldex Therapeutics, Inc. Wants You to Know
Jul 13 / MotleyFool.com - Paid Partner Content
Biogen Should Either a Buyer or a Seller Be
Jul 22 / TheStreet.com - Paid Partner Content
Pfizer (PFE) Gets FDA Nod for Label Expansion of Prevnar 13
Jul 13 / Zacks.com - Paid Partner Content
Roche's Gazyva Fails in Phase III B-cell Lymphoma Study
Jul 18 / Zacks.com - Paid Partner Content